Authors


Timothy Nugent, FTI Consulting

Latest:

A Process-Based Approach To Aggregate Spend

A Process-Based Assessment (PBA) is the first step to analyzing reporting needs


Gautam Jaggi, Ernst & Young Biotechnology Center

Latest:

Reshaping Biotechnology's Financing Relay Race

The current economic downturn may fuel the creation of new, more sustainable business models


Dan Hurry

Latest:

Three Areas to Drive Supply Chain Value

Strategic and proactive thinking are vital in providing supply chain leaders with an opportunity to shift their focus to a more holistic, value-centered approach.



Dana Edwards

Latest:

Optimizing the Patient Journey Through High-Touch, High-Tech Services for Innovative and Novel Therapies

Dana Edwards shares strategies and best practices for developing and implementing high-tech, high-touch patient support programs for innovative and novel therapies to help connect patients to the services they need.


Riccardo Butta, Stevanato Group

Latest:

Manufacturing at the Speed of AI

How pharma can harness digitalization all the way through commercialization


Akshay Kapadia

Latest:

Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation Expertise

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.


Liza Dzhezhora

Latest:

Fostering Patient Engagement with Portals

Six engagement tips for companies to consider to improve patient use of portals


Eric Solis, Takeda, and Mark Schulman, Veeva Systems

Latest:

How pharma and HCPs can support backlogged pandemic patients

Focusing on key groups will drive the greatest impact in health outcomes


Michael Carr, AssistRx

Latest:

Adding Might to ‘Specialty Lite’

Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market


Steve Beda

Latest:

Why Reliable Pharma Shipping Outweighs Cost

Although companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.


Alex Kleinman and Erin Lloyd

Latest:

From Toggling Tediously Between Systems to Achieving Whole-Person Care

The rationale behind transforming case management in healthcare.


Max Kelleher and Hartmut Hahn

Latest:

Navigating Digital Transformation Fatigue: The Strategy for Success in Regulated Industries

Digital transformation initiatives are often complex endeavors that can significantly impact the way organizations operate.


Nancy Dreyer, IQVIA

Latest:

The True Reliability of Real-World Data

Outlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support


Aida Demneri

Latest:

Harnessing the Potential of Data to Deliver the Future of Healthcare

Faster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.


Rachel Thorpe, MBA, Otsuka Patient Assistance Foundation

Latest:

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.


Yvonne Duckworth

Latest:

Developing Your Roadmap to Pharma 4.0

Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.


Allen Putman

Latest:

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.


David L. Buss, DB Schenker North America

Latest:

Patient Centricity in the Pharma Supply Chain

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.


Rob Truckenmiller, PharmaCord

Latest:

Patient Services: A Marathon, Not A Sprint

Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.


Lisabeth Buelt

Latest:

The Evolving Value Assessment Landscape in the US

How current frameworks influence coverage decisions and pricing negotiations.


Gwyn Plaskon, ConnectiveRx

Latest:

What Makes Hub Programs Successful?

Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible


Scott Snyder, PhD

Latest:

Measuring What Matters

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.


Martha Kirkpatrick

Latest:

From Aisles to Access: How Grocery-Based Pharmacies are Evolving into Community Health Hubs

Amid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.


Erik Cruz, Kevin Frymire, and Dan Schulman, Beghou Consulting

Latest:

Maximizing HCP engagement as the definition of a sales ‘call’ expands

How pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization


Steve Gens

Latest:

After a Decade of Regulatory Transformation, What’s Next?

Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape


Davy James

Latest:

FDA Greenlights New COVID Vaccines, Sets Eligibility Limits

FDA approves COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax targeting the LP.8.1 sublineage of SARS-CoV-2, with eligibility limited to adults aged 65 years and older and those with underlying medical conditions that place them with a high risk for severe disease.


Leigh Householder, Syneos Health

Latest:

Succeeding with Fit-for-Purpose AI

How artificial intelligence is improving the patient experience


Bharath Sundararaman

Latest:

Drug Shortages: A Chronic Problem, but New Opportunities Present Themselves

While this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue


Simon Andrews

Latest:

Developing a Successful Data & Analytics Strategy: Four Common Questions

A comprehensive data and analytics strategy is now table stakes for pharmaceutical and life science organizations, writes Simon Andrews

© 2025 MJH Life Sciences

All rights reserved.